2 assets in Hereditary Papillary Renal Cell Carcinoma

Therapeutic assets addressing Hereditary Papillary Renal Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Pamiparib Hereditary Papillary Renal Cell Carcinoma	Jonsson Comprehensive Cancer Center	P2	CCC (53)
do-2 Hereditary Papillary Renal Cell Carcinoma	DeuterOncology	P1	NR ()